Bizelesin in Treating Patients With Advanced Cancer

Completed · Phase 1

Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of bizelesin in treating patients who have advanced cancer.

Key facts

Study ID

NCT00003021

Run by

The University of Texas Health Science Center at San Antonio

Starts

1997-08-01

Expected to finish

2002-11-01

Last updated by the study team

2012-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Brooke Army Medical Center — Fort Sam Houston, Texas, United States
• Cancer Therapy & Research Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.